secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2022-06-22T23:59:59+00:00
Accession:  0001640334-22-001328
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria enters manufacturing and license agreements with BevNology for DehydraTECH CBD tech
--------------------------------------------------------------------------------

- Manufacturing operating agreement for fee-based production of DehydraTECH-enabled APIs for corporate clients.
- Five-year global non-exclusive license for hemp CBD (<0.3% THC) in bulk powders, liquids, and finished consumer products.
- Exclusions: Japan, South Korea, China; limited exclusive US rights for bulk liquids subject to minimum fee.
- No financial terms disclosed; agreements described as non-material.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033422001328/0001640334-22-001328-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033422001328/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-22-001328

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer